Literature DB >> 22128018

Deletion of tuberous sclerosis 1 in somatic cells of the murine reproductive tract causes female infertility.

Yoshihiro Tanaka1, Joo Hyun Park, Pradeep S Tanwar, Tomoko Kaneko-Tarui, Shilpi Mittal, Ho-Joon Lee, Jose M Teixeira.   

Abstract

Tumors develop with dysregulated activation of mammalian target of rapamycin (mTOR), the kinase activity of which is kept in an inactive state by a tumor suppressor dimer containing tuberous sclerosis 1 (TSC1) and TSC2. We examined whether conditional deletion of TSC1 by a knock-in allele of the anti-Müllerian hormone type 2 receptor (Amhr2) driving Cre expression and subsequent activation of mTOR in granulosa cells and in oviductal and uterine stromal cells affects fertility in female mice. Increased phosphorylation of ribosomal protein S6, a downstream target of activated mTOR, was observed in all AMHR2-expressing tissues examined, indicating loss of TSC1 activity. TSC1 deletion in granulosa cells led to the detection of significantly fewer primordial follicles in mutant mice at 12 wk, suggesting premature ovarian insufficiency, which might be related to the significantly increased time mutant mice spent in estrus. Although the number of good-quality ovulated oocytes was not significantly different compared with controls, there was a significantly higher number of degenerated oocytes after normal and superovulation, suggesting compromised oocyte quality, as well. Natural mating also showed severalfold higher numbers of degenerate bodies in the mutants that collected in bilateral swellings resembling hydrosalpinges that formed in all mice examined because of occlusion of the proximal oviduct. Attempts to transfer control embryos into mutant uteri also failed, indicating that implantation was compromised. Endometrial epithelial cells continued to proliferate, and quantitative RT-PCR showed that mucin 1 expression persisted during the window of implantation in mutant uteri, without any changes in progesterone receptor mRNA expression, suggesting a mechanism that does not involve disrupted estradiol-regulated progesterone receptor expression. Homozygous deletion of TSC1 in reproductive tract somatic tissues of mice rendered females completely infertile, which is likely due to these pleiotropic effects on follicle recruitment, oviductal development, and blastocyst implantation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22128018      PMCID: PMC3249683          DOI: 10.1210/en.2011-1191

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  62 in total

Review 1.  Mucins and blastocyst attachment.

Authors:  Amantha Thathiah; Daniel D Carson
Journal:  Rev Endocr Metab Disord       Date:  2002-05       Impact factor: 6.514

Review 2.  Management of infertility.

Authors:  D J Cahill; P G Wardle
Journal:  BMJ       Date:  2002-07-06

3.  Distribution of Tsc1 protein detected by immunohistochemistry in various normal rat tissues and the renal carcinomas of Eker rat: detection of limited colocalization with Tsc1 and Tsc2 gene products in vivo.

Authors:  T Fukuda; T Kobayashi; S Momose; H Yasui; O Hino
Journal:  Lab Invest       Date:  2000-09       Impact factor: 5.662

Review 4.  Mechanisms of action of estrogen and progesterone.

Authors:  Francesco J DeMayo; Bihong Zhao; Norio Takamoto; Sophia Y Tsai
Journal:  Ann N Y Acad Sci       Date:  2002-03       Impact factor: 5.691

Review 5.  Müllerian inhibiting substance: an instructive developmental hormone with diagnostic and possible therapeutic applications.

Authors:  J Teixeira; S Maheswaran; P K Donahoe
Journal:  Endocr Rev       Date:  2001-10       Impact factor: 19.871

Review 6.  New insights into the mechanisms underlying hydrosalpinx fluid formation and its adverse effect on IVF outcome.

Authors:  Louis Chukwuemeka Ajonuma; Ernest Hung Yu Ng; Hsiao Chang Chan
Journal:  Hum Reprod Update       Date:  2002 May-Jun       Impact factor: 15.610

7.  Role of foxj1 and estrogen receptor alpha in ciliated epithelial cell differentiation of the neonatal oviduct.

Authors:  A Okada; Y Ohta; S L Brody; H Watanabe; A Krust; P Chambon; T Iguchi
Journal:  J Mol Endocrinol       Date:  2004-06       Impact factor: 5.098

8.  Requirement of Bmpr1a for Müllerian duct regression during male sexual development.

Authors:  Soazik P Jamin; Nelson A Arango; Yuji Mishina; Mark C Hanks; Richard R Behringer
Journal:  Nat Genet       Date:  2002-10-07       Impact factor: 38.330

9.  Follicle-stimulating hormone activation of hypoxia-inducible factor-1 by the phosphatidylinositol 3-kinase/AKT/Ras homolog enriched in brain (Rheb)/mammalian target of rapamycin (mTOR) pathway is necessary for induction of select protein markers of follicular differentiation.

Authors:  Hena Alam; Evelyn T Maizels; Youngkyu Park; Shail Ghaey; Zachary J Feiger; Navdeep S Chandel; Mary Hunzicker-Dunn
Journal:  J Biol Chem       Date:  2004-02-24       Impact factor: 5.157

Review 10.  Etiology and pathogenesis of uterine leiomyomas: a review.

Authors:  Gordon P Flake; Janet Andersen; Darlene Dixon
Journal:  Environ Health Perspect       Date:  2003-06       Impact factor: 9.031

View more
  19 in total

1.  Loss of LKB1 and PTEN tumor suppressor genes in the ovarian surface epithelium induces papillary serous ovarian cancer.

Authors:  Pradeep S Tanwar; Gayatry Mohapatra; Sarah Chiang; David A Engler; Lihua Zhang; Tomoko Kaneko-Tarui; Yasuyo Ohguchi; Michael J Birrer; Jose M Teixeira
Journal:  Carcinogenesis       Date:  2013-10-29       Impact factor: 4.944

Review 2.  Epidemiological and genetic clues for molecular mechanisms involved in uterine leiomyoma development and growth.

Authors:  Arno E Commandeur; Aaron K Styer; Jose M Teixeira
Journal:  Hum Reprod Update       Date:  2015-07-03       Impact factor: 15.610

3.  Hyperplasia and fibrosis in mice with conditional loss of the TSC2 tumor suppressor in Müllerian duct mesenchyme-derived myometria.

Authors:  Tomoko Kaneko-Tarui; Arno E Commandeur; Amanda L Patterson; Justin L DeKuiper; David Petillo; Aaron K Styer; Jose M Teixeira
Journal:  Mol Hum Reprod       Date:  2014-09-04       Impact factor: 4.025

4.  Conditional deletion of Tsc1 in the female reproductive tract impedes normal oviductal and uterine function by enhancing mTORC1 signaling in mice.

Authors:  Takiko Daikoku; Mikihiro Yoshie; Huirong Xie; Xiaofei Sun; Jeeyeon Cha; Lora Hedrick Ellenson; Sudhansu K Dey
Journal:  Mol Hum Reprod       Date:  2013-03-07       Impact factor: 4.025

5.  Specific deletion of LKB1/Stk11 in the Müllerian duct mesenchyme drives hyperplasia of the periurethral stroma and tumorigenesis in male mice.

Authors:  Jitu W George; Amanda L Patterson; Pradeep S Tanwar; André Kajdacsy-Balla; Gail S Prins; Jose M Teixeira
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-13       Impact factor: 11.205

6.  Altered LKB1/AMPK/TSC1/TSC2/mTOR signaling causes disruption of Sertoli cell polarity and spermatogenesis.

Authors:  Pradeep S Tanwar; Tomoko Kaneko-Tarui; LiHua Zhang; Jose M Teixeira
Journal:  Hum Mol Genet       Date:  2012-07-12       Impact factor: 6.150

Review 7.  Role of TSC1 in physiology and diseases.

Authors:  Karthik Mallela; Arun Kumar
Journal:  Mol Cell Biochem       Date:  2021-02-11       Impact factor: 3.396

8.  Specific disruption of Tsc1 in ovarian granulosa cells promotes ovulation and causes progressive accumulation of corpora lutea.

Authors:  Lin Huang; Zhen-Bo Wang; Zong-Zhe Jiang; Meng-Wen Hu; Fei Lin; Qing-Hua Zhang; Yi-Bo Luo; Yi Hou; Yong Zhao; Heng-Yu Fan; Heide Schatten; Qing-Yuan Sun
Journal:  PLoS One       Date:  2013-01-15       Impact factor: 3.240

9.  Technical challenges and limitations of current mouse models of ovarian cancer.

Authors:  Kenneth Garson; Lisa F Gamwell; Elizabeth Mg Pitre; Barbara C Vanderhyden
Journal:  J Ovarian Res       Date:  2012-11-29       Impact factor: 4.234

10.  Stromal liver kinase B1 [STK11] signaling loss induces oviductal adenomas and endometrial cancer by activating mammalian Target of Rapamycin Complex 1.

Authors:  Pradeep S Tanwar; Tomoko Kaneko-Tarui; Lihua Zhang; Yoshihiro Tanaka; Christopher P Crum; Jose M Teixeira
Journal:  PLoS Genet       Date:  2012-08-16       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.